Exelixis Inc Operating Cash Flow
Exelixis Inc (EXEL) reported Operating Cash Flow of $559.59 million for the 6-month period ending 2026-07-03, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-05
- Exelixis Inc net cash provided by (used in) operating activities for the quarter ending 2026-07-03 was $307.74M, a 528.13% increase year-over-year.
- Exelixis Inc net cash provided by (used in) operating activities for the quarter ending 2026-04-03 was $251.84M, a 19.11% increase year-over-year.
- Exelixis Inc net cash provided by (used in) operating activities for the quarter ending 2026-01-02 was $333.51M, a 38.81% increase year-over-year.
- Exelixis Inc net cash provided by (used in) operating activities for the quarter ending 2025-10-03 was $290.32M, a 7.00% increase year-over-year.
- Exelixis Inc net cash provided by (used in) operating activities for fiscal 2026 was $884.27M, a 26.33% increase from fiscal 2025.
- Exelixis Inc net cash provided by (used in) operating activities for fiscal 2025 was $699.97M, a 110.00% increase from fiscal 2023.
- Exelixis Inc net cash provided by (used in) operating activities for fiscal 2023 was $333.32M, a 8.08% decline from fiscal 2022.
- Exelixis Inc net cash provided by (used in) operating activities for fiscal 2022 was $362.61M, a 9.53% decline from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 3 month as first filed | Net Cash Provided by (Used in) Operating Activities 6 month | Net Cash Provided by (Used in) Operating Activities 6 month as first filed | Net Cash Provided by (Used in) Operating Activities 9 month | Net Cash Provided by (Used in) Operating Activities 9 month as first filed | Net Cash Provided by (Used in) Operating Activities 12 month |
|---|---|---|---|---|---|---|---|
| 2026-07-03 | $307.74M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $559.59M 10-Q · filed 2026-08-05 | $893.10M derived: sum of 3 quarters · filed 2026-08-05 | $1.18B derived: sum of 4 quarters · filed 2026-08-05 | |||
| 2026-04-03 | $251.84M 10-Q · filed 2026-05-05 | $585.36M derived: sum of 2 quarters · filed 2026-05-05 | $875.68M derived: sum of 3 quarters · filed 2026-05-05 | $924.67M derived: sum of 4 quarters · filed 2026-08-05 | |||
| 2026-01-02 | $333.51M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $623.84M derived: sum of 2 quarters · filed 2026-02-10 | $672.83M derived: sum of 3 quarters · filed 2026-08-05 | $884.27M 10-K · filed 2026-02-10 | |||
| 2025-10-03 | $290.32M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $339.31M derived: sum of 2 quarters · filed 2026-08-05 | $550.75M 10-Q · filed 2025-11-04 | $791.01M derived: sum of 4 quarters · filed 2026-08-05 | |||
| 2025-07-04 | $48.99M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $260.43M 10-Q · filed 2026-08-05 | $500.69M derived: sum of 3 quarters · filed 2026-08-05 | $772.03M derived: sum of 4 quarters · filed 2026-08-05 | |||
| 2025-04-04 | $211.44M 10-Q · filed 2026-05-05 | $451.70M derived: sum of 2 quarters · filed 2026-05-05 | $723.04M derived: sum of 3 quarters · filed 2026-05-05 | $842.59M derived: sum of 4 quarters · filed 2026-05-05 | |||
| 2025-01-03 | $240.26M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $511.60M derived: sum of 2 quarters · filed 2026-02-10 | $631.15M derived: sum of 3 quarters · filed 2026-02-10 | $699.97M 10-K · filed 2026-02-10 | |||
| 2024-09-27 | $271.34M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $390.89M derived: sum of 2 quarters · filed 2025-11-04 | $459.71M 10-Q · filed 2025-11-04 | $470.28M derived: sum of 4 quarters · filed 2026-02-10 | |||
| 2024-06-28 | $119.55M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-07-28 | $188.37M 10-Q · filed 2025-07-28 | $198.94M derived: sum of 3 quarters · filed 2026-02-10 | $316.31M derived: sum of 4 quarters · filed 2026-02-10 | |||
| 2024-03-29 | $68.82M 10-Q · filed 2025-05-13 | $79.39M derived: sum of 2 quarters · filed 2026-02-10 | $196.76M derived: sum of 3 quarters · filed 2026-02-10 | $317.74M derived: sum of 4 quarters · filed 2026-02-10 | |||
| 2023-12-29 | $10.57M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-10 | $127.94M derived: sum of 2 quarters · filed 2026-02-10 | $248.92M derived: sum of 3 quarters · filed 2026-02-10 | $333.32M 10-K · filed 2026-02-10 | |||
| 2023-09-29 | $117.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-29 | $238.34M derived: sum of 2 quarters · filed 2024-10-29 | $322.75M 10-Q · filed 2024-10-29 | $396.45M derived: sum of 4 quarters · filed 2025-02-11 | |||
| 2023-06-30 | $120.98M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $205.39M 10-Q · filed 2024-08-06 | $279.08M derived: sum of 3 quarters · filed 2025-02-11 | $389.15M derived: sum of 4 quarters · filed 2025-02-11 | |||
| 2023-03-31 | $84.41M 10-Q · filed 2024-04-30 | $158.10M derived: sum of 2 quarters · filed 2025-02-11 | $268.17M derived: sum of 3 quarters · filed 2025-02-11 | $299.30M derived: sum of 4 quarters · filed 2025-02-11 | |||
| 2022-12-30 | $73.69M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-11 | $183.76M derived: sum of 2 quarters · filed 2025-02-11 | $214.90M derived: sum of 3 quarters · filed 2025-02-11 | $362.61M 10-K · filed 2025-02-11 | |||
| 2022-09-30 | $110.07M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | $141.20M derived: sum of 2 quarters · filed 2023-11-01 | $288.92M 10-Q · filed 2023-11-01 | $385.37M derived: sum of 4 quarters · filed 2024-02-06 | |||
| 2022-07-01 | $31.13M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-01 | $178.85M 10-Q · filed 2023-08-01 | $275.30M derived: sum of 3 quarters · filed 2024-02-06 | $358.61M derived: sum of 4 quarters · filed 2024-02-06 | |||
| 2022-04-01 | $147.72M 10-Q · filed 2023-05-09 | $244.17M derived: sum of 2 quarters · filed 2024-02-06 | $327.48M derived: sum of 3 quarters · filed 2024-02-06 | $508.98M derived: sum of 4 quarters · filed 2024-02-06 | |||
| 2021-12-31 | $96.45M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-06 | $179.76M derived: sum of 2 quarters · filed 2024-02-06 | $361.26M derived: sum of 3 quarters · filed 2024-02-06 | $400.80M 10-K · filed 2024-02-06 | |||
| 2021-10-01 | $83.31M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-01 | $264.81M derived: sum of 2 quarters · filed 2022-11-01 | $304.35M 10-Q · filed 2022-11-01 | $337.64M derived: sum of 4 quarters · filed 2023-02-07 | |||
| 2021-07-02 | $181.50M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $221.04M 10-Q · filed 2022-08-09 | $254.34M derived: sum of 3 quarters · filed 2023-02-07 | $272.28M derived: sum of 4 quarters · filed 2023-02-07 | |||
| 2021-04-02 | $39.54M 10-Q · filed 2022-05-10 | $72.84M derived: sum of 2 quarters · filed 2023-02-07 | $90.78M derived: sum of 3 quarters · filed 2023-02-07 | $192.45M derived: sum of 4 quarters · filed 2023-02-07 | |||
| 2021-01-01 | $33.29M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-07 | $51.23M derived: sum of 2 quarters · filed 2023-02-07 | $152.91M derived: sum of 3 quarters · filed 2023-02-07 | $208.98M 10-K · filed 2023-02-07 | |||
| 2020-10-02 | $17.94M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | $119.61M derived: sum of 2 quarters · filed 2021-11-02 | $175.69M 10-Q · filed 2021-11-02 | $333.71M derived: sum of 4 quarters · filed 2022-02-18 | |||
| 2020-07-03 | $101.68M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $157.75M 10-Q · filed 2021-08-05 | $315.77M derived: sum of 3 quarters · filed 2022-02-18 | $391.39M derived: sum of 4 quarters · filed 2022-02-18 | |||
| 2020-04-03 | $56.07M 10-Q · filed 2021-05-06 | $214.09M derived: sum of 2 quarters · filed 2022-02-18 | $289.71M derived: sum of 3 quarters · filed 2022-02-18 | $421.44M derived: sum of 4 quarters · filed 2022-02-18 | |||
| 2020-01-03 | $158.02M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-18 | $233.63M derived: sum of 2 quarters · filed 2022-02-18 | $365.36M derived: sum of 3 quarters · filed 2022-02-18 | $526.96M 10-K · filed 2022-02-18 | |||
| 2019-09-27 | $75.61M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $207.34M derived: sum of 2 quarters · filed 2020-11-05 | $368.94M 10-Q · filed 2020-11-05 | $473.53M derived: sum of 4 quarters · filed 2020-11-05 | |||
| 2019-06-28 | $131.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $293.32M 10-Q · filed 2020-08-06 | $397.91M derived: sum of 3 quarters · filed 2020-08-06 | $562.77M derived: sum of 4 quarters · filed 2020-08-06 | |||
| 2019-03-29 | $161.59M 10-Q · filed 2020-05-05 | $266.18M derived: sum of 2 quarters · filed 2020-05-05 | $431.04M derived: sum of 3 quarters · filed 2020-05-05 | $505.50M derived: sum of 4 quarters · filed 2020-05-05 | |||
| 2018-12-28 | $104.59M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $269.45M derived: sum of 2 quarters · filed 2020-02-25 | $343.91M derived: sum of 3 quarters · filed 2020-02-25 | $415.72M 10-K · filed 2021-02-11 | |||
| 2018-09-28 | $164.86M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-30 | $239.32M derived: sum of 2 quarters · filed 2019-10-30 | $311.13M 10-Q · filed 2019-10-30 | $364.48M derived: sum of 4 quarters · filed 2020-02-25 | |||
| 2018-06-29 | $74.47M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-31 | $146.27M 10-Q · filed 2019-07-31 | $146.58M 10-Q · filed 2018-08-01 | $199.63M derived: sum of 3 quarters · filed 2020-02-25 | $237.49M derived: sum of 4 quarters · filed 2020-02-25 | ||
| 2018-03-30 | $71.81M 10-Q · filed 2019-05-01 | $125.16M derived: sum of 2 quarters · filed 2020-02-25 | $163.03M derived: sum of 3 quarters · filed 2020-02-25 | ||||
| 2017-12-29 | $53.35M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $91.22M derived: sum of 2 quarters · filed 2020-02-25 | $165.61M 10-K · filed 2020-02-25 | ||||
| 2017-09-30 | $37.87M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-01 | $112.26M 10-Q · filed 2017-11-01 | |||||
| 2017-09-29 | $37.87M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | $43.40M derived: sum of 2 quarters · filed 2018-11-01 | $112.26M 10-Q · filed 2018-11-01 | $193.26M derived: sum of 4 quarters · filed 2018-11-01 | |||
| 2017-06-30 | $5.54M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02 | $74.39M 10-Q · filed 2017-08-02 | $155.39M derived: sum of 3 quarters · filed 2018-05-02 | $149.61M derived: sum of 4 quarters · filed 2018-05-02 | |||
| 2017-03-31 | $68.86M 10-Q · filed 2017-05-01 | $149.86M derived: sum of 2 quarters · filed 2018-05-02 | $144.08M derived: sum of 3 quarters · filed 2018-05-02 | $118.34M derived: sum of 4 quarters · filed 2018-05-02 | |||
| 2016-12-31 | $81.00M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | $75.22M derived: sum of 2 quarters · filed 2017-11-01 | $49.49M derived: sum of 3 quarters · filed 2017-11-01 | $206.30M 10-K · filed 2017-02-27 | |||
| 2016-12-30 | $210.40M 10-K · filed 2019-02-22 | ||||||
| 2016-09-30 | -$5.78M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-01 | -$31.52M derived: sum of 2 quarters · filed 2017-11-01 | $125.30M 10-Q · filed 2017-11-01 | $122.58M 10-Q · filed 2016-11-03 | $89.86M derived: sum of 4 quarters · filed 2017-11-01 | ||
| 2016-06-30 | -$25.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02 | $131.08M 10-Q · filed 2017-08-02 | $129.02M 10-Q · filed 2016-08-03 | $95.64M derived: sum of 3 quarters · filed 2017-08-02 | $61.41M derived: sum of 4 quarters · filed 2017-08-02 | ||
| 2016-03-31 | $156.81M 10-Q · filed 2017-05-01 | $154.90M 10-Q · filed 2016-05-04 | $121.38M derived: sum of 2 quarters · filed 2017-05-01 | $87.14M derived: sum of 3 quarters · filed 2017-05-01 | $60.31M derived: sum of 4 quarters · filed 2017-05-01 | ||
| 2016-01-01 | -$141.05M 10-K · filed 2018-02-26 | ||||||
| 2015-12-31 | -$35.43M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | -$69.67M derived: sum of 2 quarters · filed 2017-02-27 | -$96.50M derived: sum of 3 quarters · filed 2017-02-27 | -$141.59M 10-K · filed 2017-02-27 | |||
| 2015-09-30 | -$34.23M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | -$61.07M derived: sum of 2 quarters · filed 2016-11-03 | -$106.15M 10-Q · filed 2016-11-03 | -$156.13M derived: sum of 4 quarters · filed 2017-02-27 | |||
| 2015-06-30 | -$26.83M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-03 | -$71.92M 10-Q · filed 2016-08-03 | -$121.89M derived: sum of 3 quarters · filed 2017-02-27 | -$179.90M derived: sum of 4 quarters · filed 2017-02-27 | |||
| 2015-03-31 | -$45.09M 10-Q · filed 2016-05-04 | -$95.06M derived: sum of 2 quarters · filed 2017-02-27 | -$153.07M derived: sum of 3 quarters · filed 2017-02-27 | -$208.41M derived: sum of 4 quarters · filed 2017-02-27 | |||
| 2014-12-31 | -$49.98M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-27 | -$107.98M derived: sum of 2 quarters · filed 2017-02-27 | -$163.32M derived: sum of 3 quarters · filed 2017-02-27 | -$235.41M 10-K · filed 2017-02-27 | |||
| 2014-09-30 | -$58.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-10 | -$113.34M derived: sum of 2 quarters · filed 2015-11-10 | -$185.43M 10-Q · filed 2015-11-10 | -$232.76M derived: sum of 4 quarters · filed 2016-02-29 | |||
| 2014-06-30 | -$55.34M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-11 | -$127.42M 10-Q · filed 2015-08-11 | -$174.75M derived: sum of 3 quarters · filed 2016-02-29 | -$231.75M derived: sum of 4 quarters · filed 2016-02-29 | |||
| 2014-03-31 | -$72.09M 10-Q · filed 2015-04-30 | -$119.42M derived: sum of 2 quarters · filed 2016-02-29 | -$176.41M derived: sum of 3 quarters · filed 2016-02-29 | -$216.44M derived: sum of 4 quarters · filed 2016-02-29 | |||
| 2013-12-31 | -$47.33M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | -$104.32M derived: sum of 2 quarters · filed 2016-02-29 | -$144.36M derived: sum of 3 quarters · filed 2016-02-29 | -$198.77M 10-K · filed 2016-02-29 | |||
| 2013-09-30 | -$56.99M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-04 | -$97.03M derived: sum of 2 quarters · filed 2014-11-04 | -$151.44M 10-Q · filed 2014-11-04 | -$190.18M derived: sum of 4 quarters · filed 2015-03-02 | |||
| 2013-06-30 | -$40.03M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-07-31 | -$94.45M 10-Q · filed 2014-07-31 | -$133.19M derived: sum of 3 quarters · filed 2015-03-02 | -$167.24M derived: sum of 4 quarters · filed 2015-03-02 | |||
| 2013-03-31 | -$54.41M 10-Q · filed 2014-05-01 | -$93.15M derived: sum of 2 quarters · filed 2015-03-02 | -$127.20M derived: sum of 3 quarters · filed 2015-03-02 | -$162.59M derived: sum of 4 quarters · filed 2015-03-02 | |||
| 2012-12-31 | -$38.74M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | -$72.79M derived: sum of 2 quarters · filed 2015-03-02 | -$108.18M derived: sum of 3 quarters · filed 2015-03-02 | -$123.15M 10-K · filed 2015-03-02 | |||
| 2012-09-30 | -$34.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-10-30 | -$69.44M derived: sum of 2 quarters · filed 2013-10-30 | -$84.41M 10-Q · filed 2013-10-30 | -$113.58M derived: sum of 4 quarters · filed 2014-02-20 | |||
| 2012-06-30 | -$35.39M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-06 | -$50.36M 10-Q · filed 2013-08-06 | -$79.53M derived: sum of 3 quarters · filed 2014-02-20 | -$122.80M derived: sum of 4 quarters · filed 2014-02-20 | |||
| 2012-03-31 | -$14.97M 10-Q · filed 2013-05-07 | -$44.14M derived: sum of 2 quarters · filed 2014-02-20 | -$87.41M derived: sum of 3 quarters · filed 2014-02-20 | -$130.92M derived: sum of 4 quarters · filed 2014-02-20 | |||
| 2011-12-31 | -$29.17M derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-20 | -$72.44M derived: sum of 2 quarters · filed 2014-02-20 | -$115.96M derived: sum of 3 quarters · filed 2014-02-20 | -$159.23M 10-K · filed 2014-02-20 | |||
| 2011-09-30 | -$43.27M derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-07 | -$86.78M derived: sum of 2 quarters · filed 2012-11-07 | -$130.06M 10-Q · filed 2012-11-07 | -$108.81M derived: sum of 4 quarters · filed 2013-02-21 | |||
| 2011-06-30 | -$43.52M derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-02 | -$86.79M 10-Q · filed 2012-08-02 | -$65.54M derived: sum of 3 quarters · filed 2013-02-21 | -$109.36M derived: sum of 4 quarters · filed 2013-02-21 | |||
| 2011-03-31 | -$43.28M 10-Q · filed 2012-05-03 | -$22.02M derived: sum of 2 quarters · filed 2013-02-21 | -$65.85M derived: sum of 3 quarters · filed 2013-02-21 | ||||
| 2010-12-31 | $21.25M derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-21 | -$22.57M derived: sum of 2 quarters · filed 2013-02-21 | -$101.05M 10-K · filed 2013-02-21 | ||||
| 2010-09-30 | -$43.83M derived: 10-Q 9 month − 10-Q 6 month · filed 2011-10-27 | -$122.30M 10-Q · filed 2011-10-27 | |||||
| 2010-06-30 | -$78.47M 10-Q · filed 2011-08-04 | ||||||
| 2009-12-31 | -$14.59M 10-K · filed 2012-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |